SMSPHARMA
Invest with MTF
Invest Now
Invest in SMS Pharmaceuticals with 2.68X leverage
Performance
- Low
- ₹326
- High
- ₹342
- 52 Week Low
- ₹176
- 52 Week High
- ₹342
- Open Price₹331
- Previous Close₹326
- Volume1,107,601
Investment Returns
- Over 1 Month + 5.9%
- Over 3 Month + 24.87%
- Over 6 Month + 37.89%
- Over 1 Year + 31.2%
Smart Investing Starts Here Start SIP with SMS Pharmaceuticals for Steady Growth!
SMS Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 35.3
- PEG Ratio
- 0.8
- Market Cap Cr
- 2,976
- P/B Ratio
- 4.1
- Average True Range
- 12.13
- EPS
- 9.01
- Dividend Yield
- 0.1
- MACD Signal
- 4.04
- RSI
- 65.29
- MFI
- 69.02
SMS Pharmaceuticals Financials
SMS Pharmaceuticals Technicals
EMA & SMA
Current Price
₹335.70
+
9.45
(2.9%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹314.81
- 50 Day
- ₹303.64
- 100 Day
- ₹287.83
- 200 Day
- ₹270.22
Resistance and Support
334.65
- R3 358.50
- R2 350.20
- R1 342.95
- S1 327.40
- S2 319.10
- S3 311.85
SMS Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-08 | Quarterly Results | |
| 2025-08-09 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2025-05-30 | Audited Results & Final Dividend | |
| 2025-02-12 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2024-11-08 | Quarterly Results |
SMS Pharmaceuticals F&O
About SMS Pharmaceuticals
- NSE Symbol
- SMSPHARMA
- BSE Symbol
- 532815
- Chairman & Managing Director
- Mr. Ramesh Babu Potluri
- ISIN
- INE812G01025
Similar Stocks to SMS Pharmaceuticals
SMS Pharmaceuticals FAQs
SMS Pharmaceuticals share price is ₹335 As on 06 January, 2026 | 07:17
The Market Cap of SMS Pharmaceuticals is ₹2976 Cr As on 06 January, 2026 | 07:17
The P/E ratio of SMS Pharmaceuticals is 35.3 As on 06 January, 2026 | 07:17
The PB ratio of SMS Pharmaceuticals is 4.1 As on 06 January, 2026 | 07:17
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.